Dr. Clay Siegall: In Pursuit of Greatness

There are many brilliant-minded individuals in this world and many of these people are working in cancer research. This is one of the most demanding industries on earth, but is has also saved hundreds of thousands of lives on a worldwide-scale. The industry has been buzzing with activity as of late because of all the new discoveries. Some discoveries are good while others aren’t so good. Lets dig a bit deeper on this topic of discussion. Revolutionary-science is changing the game when it comes to fighting cancer. Some of the most technologically advanced medications are on the market right now, and they are saving lives at a dramatic rate. Antibody-based conjugates have helped to revolutionize the industry thanks to their wonderful lifesaving benefits.

Seattle Genetics, a Washington-based oncology company, is at the forefront of it all. Dr. Clay Siegall co-founded this organization back in 1998, and it has produced some amazing cancer-fighting medications. The company’s flagship drug, ADCETRIS, is now being used in 66 countries worldwide. This cancer therapy is aggressive at attacking cancer cells within the body, but it by-passes all of the good cells. This drastically cuts-back on sickening side effects, which is a bonus for all patients. Dr. Siegall has implemented his strong principles of drug development, scientific innovation and rigorous research into each and every medication. In other words, the mortality rate is much lower with (ADCs) on the scene. On the other hand, there are other specific types of cancer that these medications can’t fight. The National Cancer Institute reported that a shocking 40 percent of men and women will be diagnosed with cancer in their lifetime.

Hodgkin’s Lymphoma affects young people more so than other older people. Studies show that 8,000 new cases are present each year among this group. The problem is that most people don’t have access to the medications. Research and drugs are what’s keeping the industry afloat. If cancer gets tougher, then cancer research will get tougher and Dr. Clay Siegall has a firm understanding of this. This is the new wave of cancer-breakthrough therapies and the future is still looking very promising.